# Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses

> **NCT06545396** · NA · NOT_YET_RECRUITING · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 20 (estimated)

## Conditions studied

- Actinic Keratoses

## Interventions

- **OTHER:** Half-dose illumination protocol
- **OTHER:** Full-dose illumination protocol

## Key facts

- **NCT ID:** NCT06545396
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545396, "Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06545396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
